Patents by Inventor Stanley Joseph Gross

Stanley Joseph Gross has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4097586
    Abstract: Haptens and antigen derivatives are coupled, through an azo bond, to proteins to form a conjugated material. The conjugate is injected into laboratory animals to raise antibodies which are useful in immunochemically assaying for the original haptens and antigen derivatives. Included among the immunochemical assay methods are radio-immune assays and fluorescence methods.
    Type: Grant
    Filed: February 17, 1976
    Date of Patent: June 27, 1978
    Assignee: Biological Developments, Inc.
    Inventor: Stanley Joseph Gross
  • Patent number: 4064228
    Abstract: Antigens capable of generating antibodies specific to morphine and other 3-oxybenzomorphan compounds are prepared by conjugating 3-oxybenzomorphan derivatives with immunogenic carriers employing a linking site on an aryl group of the 3-oxybenzomorphan other than the hydroxyl substituent, so as to produce antibodies specific for the material.
    Type: Grant
    Filed: May 19, 1975
    Date of Patent: December 20, 1977
    Assignee: Biological Developments, Inc.
    Inventor: Stanley Joseph Gross
  • Patent number: 3996344
    Abstract: Antigenic phenethylamine conjugates are produced by blocking the amine of the phenethylamine hapten with a group, coupling of the phenethylamine to a carrier, and removal of the blocking group. Specific phenethylamines useful in this invention are amphetamine, epinephrine, and norepinephrine. The antigens thus produced can be used to raise antibodies in animal bodies, the antibodies being specific to the phenethylamine compound employed. The antibodies are useful in assaying for the phenethylamine hapten compounds.
    Type: Grant
    Filed: December 10, 1974
    Date of Patent: December 7, 1976
    Assignee: Biological Developments, Inc.
    Inventor: Stanley Joseph Gross
  • Patent number: 3995021
    Abstract: Antigens comprising 5,5'-alkylphenyl barbituric acid haptens and related 5,5'-phenylhydantoin haptens coupled to a carrier through an azo group connected meta or para on the phenyl ring are prepared by diazotization of the corresponding amine. Specific antibodies are raised in animals and used in radioimmuno assays for the corresponding hapten.
    Type: Grant
    Filed: January 21, 1975
    Date of Patent: November 30, 1976
    Assignee: Biological Developments, Inc.
    Inventor: Stanley Joseph Gross
  • Patent number: 3975342
    Abstract: Tyrosyl, thyronine, and histidyl compounds of the formulas: ##SPC1##Where R' is selected from the group consisting of --OH and --NHP.sub.p and R" is selected from the class consisting of --H and --COP.sub.p, where P.sub.p is a polypeptide chain having from 1 to 250 peptide groups, with or without pendant groups, X is selected from the class consisting of H and I; when X is I, X' is selected from the group consisting of H and I; and n is 0 or 1, where X' is H when n is 0; are conjugated to a carrier by first forming a primary aromatic amine on the carrier, diazotizing the amine, and coupling the tyrosyl, histidyl, or thyronine through the diazo group to form a novel antigenic conjugate. This novel antigenic conjugate can be injected into an animal for production of specific antibodies which are useful in assaying for the target, particularly by radioassaying.
    Type: Grant
    Filed: March 18, 1974
    Date of Patent: August 17, 1976
    Assignee: Biological Developments, Inc.
    Inventor: Stanley Joseph Gross
  • Patent number: 3940475
    Abstract: A radioimmune method of assaying quantitatively for a hapten comprising contacting an aqueous sample containing the hapten under assay, a known quantity of a radioactively labeled marker which incorporates a hapten homologous to the hapten under assay, and an insolubilized antibody specific for the hapten under assay to competitively bind part of said labeled hapten and the hapten contained in said sample to the antibody; incubating the foregoing mixture until a two-phase system is produced comprising an insoluble or solid phase and an aqueous phase, and measuring the radioactivity of at least one of said two phases, the value of said radioactivity being a function of the concentration in said sample of the hapten under assay.
    Type: Grant
    Filed: July 7, 1971
    Date of Patent: February 24, 1976
    Assignee: Biological Developments, Inc.
    Inventor: Stanley Joseph Gross